Cargando…
Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia
Childhood acute lymphoblastic leukemia (ALL) genomes show that relapses often arise from subclonal outgrowths. However, the impact of clonal evolution on the actionable proteome and response to targeted therapy is not known. Here, we present a comprehensive retrospective analysis of paired ALL diagn...
Autores principales: | Lorentzian, Amanda C., Rever, Jenna, Ergin, Enes K., Guo, Meiyun, Akella, Neha M., Rolf, Nina, James Lim, C., Reid, Gregor S. D., Maxwell, Christopher A., Lange, Philipp F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663560/ https://www.ncbi.nlm.nih.gov/pubmed/37989729 http://dx.doi.org/10.1038/s41467-023-42701-9 |
Ejemplares similares
-
Centrosome Amplification Is a Potential Molecular Target in Paediatric Acute Lymphoblastic Leukemia
por: Guo, Meiyun, et al.
Publicado: (2022) -
PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways
por: Uzozie, Anuli C., et al.
Publicado: (2021) -
A cross‐standardized flow cytometry platform to assess phenotypic stability in precursor B‐cell acute lymphoblastic leukemia (B‐ALL) xenografts
por: Rolf, Nina, et al.
Publicado: (2021) -
Adaptation of the Th-MYCN Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease
por: Rahavi, Seyed M., et al.
Publicado: (2023) -
Diet as a Potential Moderator for Genome Stability and Immune Response in Pediatric Leukemia
por: Wang, Shanshan, et al.
Publicado: (2021)